Global Pet Parasite Prevention and Control Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2204150018 | Category: Pharma & Healthcare | Pages: 93 | Format: PDF | Published Date: May 12,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Pet Parasite Prevention and Control Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pet Parasite Prevention and Control Drugs market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Dog accounting for % of the Pet Parasite Prevention and Control Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Topical Medication segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pet Parasite Prevention and Control Drugs include Boehringer Ingelheim, Bayer, Zoetis, Dechra Pharmaceuticals, and Chanelle Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pet Parasite Prevention and Control Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Topical Medication
    Injection Medication
    Oral Medication
Market segment by Application can be divided into
    Dog
    Cat
    Others
The key market players for global Pet Parasite Prevention and Control Drugs market are listed below:
    Boehringer Ingelheim
    Bayer
    Zoetis
    Dechra Pharmaceuticals
    Chanelle Pharma
    Merck Animal Health
    Elanco
    Virbac
    Vetoquinol
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pet Parasite Prevention and Control Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pet Parasite Prevention and Control Drugs, with price, sales, revenue and global market share of Pet Parasite Prevention and Control Drugs from 2019 to 2022.
Chapter 3, the Pet Parasite Prevention and Control Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pet Parasite Prevention and Control Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pet Parasite Prevention and Control Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pet Parasite Prevention and Control Drugs.
Chapter 13, 14, and 15, to describe Pet Parasite Prevention and Control Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Pet Parasite Prevention and Control Drugs Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Pet Parasite Prevention and Control Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Topical Medication
        1.2.3 Injection Medication
        1.2.4 Oral Medication
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Pet Parasite Prevention and Control Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Dog
        1.3.3 Cat
        1.3.4 Others
    1.4 Global Pet Parasite Prevention and Control Drugs Market Size & Forecast
        1.4.1 Global Pet Parasite Prevention and Control Drugs Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Pet Parasite Prevention and Control Drugs Sales in Volume (2017-2028)
        1.4.3 Global Pet Parasite Prevention and Control Drugs Price (2017-2028) 
    1.5 Global Pet Parasite Prevention and Control Drugs Production Capacity Analysis
        1.5.1 Global Pet Parasite Prevention and Control Drugs Total Production Capacity (2017-2028)
        1.5.2 Global Pet Parasite Prevention and Control Drugs Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Pet Parasite Prevention and Control Drugs Market Drivers
        1.6.2 Pet Parasite Prevention and Control Drugs Market Restraints
        1.6.3 Pet Parasite Prevention and Control Drugs Trends Analysis
2 Manufacturers Profiles
    2.1 Boehringer Ingelheim
        2.1.1 Boehringer Ingelheim Details
        2.1.2 Boehringer Ingelheim Major Business
        2.1.3 Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Product and Services
        2.1.4 Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Bayer
        2.2.1 Bayer Details
        2.2.2 Bayer Major Business
        2.2.3 Bayer Pet Parasite Prevention and Control Drugs Product and Services
        2.2.4 Bayer Pet Parasite Prevention and Control Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Zoetis
        2.3.1 Zoetis Details
        2.3.2 Zoetis Major Business
        2.3.3 Zoetis Pet Parasite Prevention and Control Drugs Product and Services
        2.3.4 Zoetis Pet Parasite Prevention and Control Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Dechra Pharmaceuticals
        2.4.1 Dechra Pharmaceuticals Details
        2.4.2 Dechra Pharmaceuticals Major Business
        2.4.3 Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Product and Services
        2.4.4 Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Chanelle Pharma
        2.5.1 Chanelle Pharma Details
        2.5.2 Chanelle Pharma Major Business
        2.5.3 Chanelle Pharma Pet Parasite Prevention and Control Drugs Product and Services
        2.5.4 Chanelle Pharma Pet Parasite Prevention and Control Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Merck Animal Health
        2.6.1 Merck Animal Health Details
        2.6.2 Merck Animal Health Major Business
        2.6.3 Merck Animal Health Pet Parasite Prevention and Control Drugs Product and Services
        2.6.4 Merck Animal Health Pet Parasite Prevention and Control Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Elanco
        2.7.1 Elanco Details
        2.7.2 Elanco Major Business
        2.7.3 Elanco Pet Parasite Prevention and Control Drugs Product and Services
        2.7.4 Elanco Pet Parasite Prevention and Control Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Virbac
        2.8.1 Virbac Details
        2.8.2 Virbac Major Business
        2.8.3 Virbac Pet Parasite Prevention and Control Drugs Product and Services
        2.8.4 Virbac Pet Parasite Prevention and Control Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Vetoquinol
        2.9.1 Vetoquinol Details
        2.9.2 Vetoquinol Major Business
        2.9.3 Vetoquinol Pet Parasite Prevention and Control Drugs Product and Services
        2.9.4 Vetoquinol Pet Parasite Prevention and Control Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pet Parasite Prevention and Control Drugs Breakdown Data by Manufacturer
    3.1 Global Pet Parasite Prevention and Control Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Pet Parasite Prevention and Control Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Pet Parasite Prevention and Control Drugs
    3.4 Market Concentration Rate
        3.4.1 Top 3 Pet Parasite Prevention and Control Drugs Manufacturer Market Share in 2021
        3.4.2 Top 6 Pet Parasite Prevention and Control Drugs Manufacturer Market Share in 2021
    3.5 Global Pet Parasite Prevention and Control Drugs Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Pet Parasite Prevention and Control Drugs Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Pet Parasite Prevention and Control Drugs Market Size by Region
        4.1.1 Global Pet Parasite Prevention and Control Drugs Sales in Volume by Region (2017-2028)
        4.1.2 Global Pet Parasite Prevention and Control Drugs Revenue by Region (2017-2028)
    4.2 North America Pet Parasite Prevention and Control Drugs Revenue (2017-2028)
    4.3 Europe Pet Parasite Prevention and Control Drugs Revenue (2017-2028)
    4.4 Asia-Pacific Pet Parasite Prevention and Control Drugs Revenue (2017-2028)
    4.5 South America Pet Parasite Prevention and Control Drugs Revenue (2017-2028)
    4.6 Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Pet Parasite Prevention and Control Drugs Sales in Volume by Type (2017-2028)
    5.2 Global Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2028)
    5.3 Global Pet Parasite Prevention and Control Drugs Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Pet Parasite Prevention and Control Drugs Sales in Volume by Application (2017-2028)
    6.2 Global Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2028)
    6.3 Global Pet Parasite Prevention and Control Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
    7.2 North America Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
    7.3 North America Pet Parasite Prevention and Control Drugs Market Size by Country
        7.3.1 North America Pet Parasite Prevention and Control Drugs Sales in Volume by Country (2017-2028)
        7.3.2 North America Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
    8.2 Europe Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
    8.3 Europe Pet Parasite Prevention and Control Drugs Market Size by Country
        8.3.1 Europe Pet Parasite Prevention and Control Drugs Sales in Volume by Country (2017-2028)
        8.3.2 Europe Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
    9.2 Asia-Pacific Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
    9.3 Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size by Region
        9.3.1 Asia-Pacific Pet Parasite Prevention and Control Drugs Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Pet Parasite Prevention and Control Drugs Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
    10.2 South America Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
    10.3 South America Pet Parasite Prevention and Control Drugs Market Size by Country
        10.3.1 South America Pet Parasite Prevention and Control Drugs Sales in Volume by Country (2017-2028)
        10.3.2 South America Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
    11.2 Middle East & Africa Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
    11.3 Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size by Country
        11.3.1 Middle East & Africa Pet Parasite Prevention and Control Drugs Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Pet Parasite Prevention and Control Drugs and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Pet Parasite Prevention and Control Drugs
    12.3 Pet Parasite Prevention and Control Drugs Production Process
    12.4 Pet Parasite Prevention and Control Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Pet Parasite Prevention and Control Drugs Typical Distributors
    13.3 Pet Parasite Prevention and Control Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Pet Parasite Prevention and Control Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?